US FDA ‘Brainstorms’ For Ways To Resume Pre-Pandemic Inspection Cadence

The FDA's drug inspections director discusses trends and challenges in remarks at a Georgia GMP conference, while declining to share specific ideas generated in last week’s agency brainstorming session.